Longeveron Inc.
USD0.60
-0.02 (-3.18%)
CEO
Stephen H. Willard
IPO Date
2021-02-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.62
Prev. Close
$0.62
Day Low
$0.60
Day High
$0.63
52W Low
$0.47
52W High
$1.80
Market Cap
$0.01B
Volume
0.24M
| $0.00 |
| 13 Jul 2026 | Ascheim Deborah | director | Disposed | 0 | $0.00 |
| 8 Jul 2026 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | A-Award | Acquired | 600,000 | $0.00 |
| 8 Jul 2026 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | A-Award | Acquired | 400,000 | $0.65 |
| 6 Jul 2026 | Willard Stephen H | Chief Executive Officer | F-InKind | Disposed | 18,046 | $0.73 |
| 6 Jul 2026 | Locklear Lisa | Chief Financial Officer | F-InKind | Disposed | 22,505 | $0.73 |
| 6 Jul 2026 | Agafonova Nataliya | Chief Medical Officer | F-InKind | Disposed | 22,505 | $0.73 |
| 6 Jul 2026 | Blass Devin | CTO & SVP of CMC | F-InKind | Disposed | 15,808 | $0.73 |
| 6 Jul 2026 | Lehr Paul T | General Counsel, Secretary | F-InKind | Disposed | 13,143 | $0.73 |